Single [7] and repeated [13] infusions of the chimeric anti-tumor necrosis factor alpha (anti-TNF-α) monoclonal antibody, infliximab, beside the decrease in RA activity, diminished serum levels of MMP-1, MMP-3 and MMP-9. Here, MMP9 is linked to rheumatoid arthritis.